Alnylam Pharmaceuticals Inc (ALNY) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

ALNY rapporto: 50%

100%

ALNY supera 17 di 34 ultime stime

Data del prossimo reportNov 7, 2024

Stimato per Q3 24:$-1.12

Cambiamenti implicati per il Q2 24:+761.54%

Cambiamenti implicati per il Q3 23:-197.39%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 1, 2024	$-0.13 / $-1.19	$1.06 / 89.08%
Q1 24	May 2, 2024	$-0.52 / $-1.26	$0.74 / 58.73%
Q4 23	Feb 15, 2024	$-1.1 / $-1.2	$0.1 / 8.33%
Q3 23	Nov 2, 2023	$1.15 / $-1.61	$2.76 / 171.43%
Q2 23	Aug 3, 2023	$-2.21 / $-1.72	$-0.49 / -28.49%
Q1 23	May 4, 2023	$-1.4 / $-1.97	$0.57 / 28.93%
Q4 22	Feb 23, 2023	$-1.68 / $-2.13	$0.45 / 21.13%
Q3 22	Oct 27, 2022	$-3.32 / $-1.86	$-1.46 / -78.49%

Fornitori di Dati: Xignite Logo